Phreesia Life Sciences

The U.S. Preventive Services Task Force just lowered the recommended age for regular #mammogram screenings from 50 to 40. This is key for #breastcancer prevention and early detection that will save lives — but now the challenge is getting this simple message to patients.   Driving awareness of a new cancer screening guideline is a massive task. Millions of patients need to be informed, and the burden always falls on primary care doctors who are already overwhelmed.   The good news is technology can inform people of their risks while they are scheduling or checking in for a doctor’s appointment and encourage them to get recommended screenings. At Phreesia, we will integrate this change in guidance immediately to our patient-facing messaging to millions who need to get screened.

For many patients with rare diseases, finding a specialist experienced in their condition causes delays in care. A reported 46% of rare disease patients wait at least a year for a definitive diagnosis, and 1 in 5 wait over five years. Swipe below to learn how digital tools can help patients with complex diagnoses find the care they need.     Visit our website to learn how Phreesia and MediFind can help you support patients during their search for a provider: https://bit.ly/3w8gUFY

Treatment delays can seriously impact patients’ health outcomes. But by leveraging digital tools, healthcare stakeholders can help them find and access specialist care early in their journey. In a new BioPharma Dive article, Elizabeth Bodin, VP for Respiratory and Immunology at AstraZeneca, and Nicole Latulippe, US Brand Marketing Lead for Lung at Takeda Oncology, share insights on how to accelerate patients’ connection to quality care. Read the article: https://bit.ly/3QpOf5Z

April has been declared National Cancer Prevention and Early Detection Month. Most people don’t experience signs or symptoms of cancer until it’s in advanced stages, but you don’t need to wait for symptoms to check your health through cancer screenings. Early detection of cancer can mean less extensive treatment, more treatment options and better chances of survival. Phreesia is proud to present patients with tailored messages that encourage them to get preventive #cancer screenings, as well as educate them on diagnostic and treatment options. Here are some of the results Phreesia-delivered campaigns have produced to date: - In a lung cancer screening campaign, patients 50-80 years old with a history of smoking were 234% more likely to get screened for lung cancer after seeing the campaign. - In a breast cancer awareness campaign, more than 80% of patients found the information they saw about breast cancer risks and screenings helpful and 72% of patients said they were likely to talk to their doctor about breast cancer risk factors after seeing the campaign. - In a colorectal cancer screening campaign, Phreesia engaged patients due or overdue for a colorectal cancer screening and found that 40% of responding patients identified risk factors that placed them at elevated risk for colorectal cancer. Learn about the impact of Phreesia’s cancer prevention efforts: https://bit.ly/3UBMFjO

Modern omnichannel campaigns require the coordination of a multitude of media, but one thing is clear: Point of Care is too important to be an afterthought. This blog post includes advice from Sarah Bast, Publicis Health Media EVP, Investment Marketplace, courtesy of Phreesia Life Sciences Check it Out: https://lnkd.in/dDmrcheK

Did you know that 1 in 5 patients hasn’t filled a prescription in the past? Or that one-third of patients aren’t confident managing their illness? A recent Fierce Pharma article about medication adherence details Phreesia research findings and key insights from Sarah Walters, VP for U.S. Cardiovascular, Renal and Metabolic Diseases at AstraZeneca. Read the article to learn more: https://bit.ly/3UAhB35

Presenting patients with high-quality, relevant information at meaningful times has significant benefits, but responsible data collection and use is critical to maintaining their trust. In the latest MM+M podcast episode, Melissa Mitchell, Chief Privacy Officer at Phreesia, joins Anthony Matyjaszewski, VP, Chief Compliance Officer at NAI, to discuss actionable ways to deliver content that activates, educates and empowers patients while prioritizing privacy and consent. Listen here: https://bit.ly/4aOy8af

More than three in four adults are missing routinely recommended vaccines, and since the COVID-19 pandemic put preventive care on hold, vaccination rates have worsened. Phreesia has delivered over 20.7 million vaccine-related messages to adults since 2020. We are proud to use our platform to promote #immunizations that help prevent diseases and improve #health outcomes. To learn more about Phreesia’s immunization efforts, visit: https://bit.ly/3JjyRnU #WorldImmunizationWeek #VaccinesWork

Our Client Experience team is made up of innovative, passionate problem-solvers who leverage their diverse backgrounds to help healthcare and life sciences organizations improve patient health outcomes. Interested in joining our team? Learn more about careers at Phreesia and view our open positions: https://bit.ly/44u0e8F

Did you know approximately 20% of patients need to find a new doctor each year due to insurance, geographic or other factors? Our condition-centric, objective Doctor Finder tool helps patients find the right specialist for their condition across 1M+ U.S. physicians.  Talk with us to learn more about how MediFind can help you connect patients with better care, faster: https://bit.ly/4b4jo71